Lanier Biotherapeutics, Inc. — Form D/A
Lanier Biotherapeutics, Inc. of BOGART, GA, a company, filed a Form D amendment with the SEC on 2022-11-07. The offering totals $4.9M, of which $3.1M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-11-07
- Form: D/A
- Accession: 0001877210-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $4.9M
- Amount sold: $3.1M
- Remaining: $1.9M
- Minimum investment: $25K
- Investors: 47
- Date of first sale: 2021-07-28
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-409084
Issuer
- Name: Lanier Biotherapeutics, Inc.
- CIK: 0001877210
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 150 BEN BURTON ROAD, BOGART, GA, 30622
- Phone: 678-428-7570
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Kirby N Alton | Director | Bogart, GA |
| Christopher N McLeod | Director | Bogart, GA |
| Lewis A Scruggs | Director | Bogart, GA |
| Martin A Simonetti | Director | Bogart, GA |
| Daniel White | Director | Southfield, MI |
| Daniel White | Executive Officer | Southfield, MI |
| Daniel White | Promoter | Southfield, MI |
Other filings by this issuer (1)
More